BARCLAYS PLC - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 84 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q1 2022$18,000
-95.1%
14,104
-93.3%
0.00%
Q4 2021$370,000
+245.8%
210,896
+327.7%
0.00%
Q3 2021$107,000
-48.3%
49,306
-16.4%
0.00%
Q2 2021$207,000
-88.3%
58,987
-67.1%
0.00%
-100.0%
Q1 2021$1,767,000
-44.7%
179,246
-39.2%
0.00%
-50.0%
Q4 2020$3,194,000
-21.7%
294,782
-25.6%
0.00%0.0%
Q3 2020$4,081,000
-30.9%
396,025
+40.0%
0.00%
-60.0%
Q2 2020$5,905,000
+124.9%
282,820
+5.3%
0.01%
+150.0%
Q1 2020$2,626,000
-50.8%
268,681
-42.0%
0.00%
-33.3%
Q4 2019$5,338,000
+2069.9%
463,238
+927.1%
0.00%
Q3 2019$246,000
-75.6%
45,101
-46.9%
0.00%
Q2 2019$1,008,000
+290.7%
84,880
+72.9%
0.00%
Q1 2019$258,000
+360.7%
49,085
+174.9%
0.00%
Q4 2018$56,000
-86.6%
17,857
-74.2%
0.00%
Q3 2018$418,000
+257.3%
69,135
+211.9%
0.00%
Q2 2018$117,000
-79.0%
22,164
-76.9%
0.00%
Q1 2018$556,000
+363.3%
95,883
+178.4%
0.00%
Q4 2017$120,000
+650.0%
34,445
+674.9%
0.00%
Q3 2017$16,000
-94.4%
4,445
-96.1%
0.00%
Q2 2017$285,000
+714.3%
113,978
+756.8%
0.00%
Q1 2017$35,000
+25.0%
13,303
+36.0%
0.00%
Q4 2016$28,0009,781
+488950.0%
0.00%
Q3 2016$0
-100.0%
2
-99.6%
0.00%
Q2 2016$1,0004950.00%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q1 2019
NameSharesValueWeighting ↓
Versant Venture Management, LLC 5,068,233$17,739,0005.88%
Sonic Fund II, L.P. 6,552,068$22,932,0001.69%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 480,000$1,680,0000.88%
Avoro Capital Advisors LLC 6,950,000$24,325,0000.42%
RTW INVESTMENTS, LP 7,357,917$25,753,0000.39%
K2 PRINCIPAL FUND, L.P. 898,307$3,144,0000.26%
Artal Group S.A. 3,000,000$10,500,0000.21%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,827,000$9,895,0000.18%
WS MANAGEMENT LLLP 307,442$1,076,0000.11%
ALGERT GLOBAL LLC 82,145$288,0000.10%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders